|
National Stock Number(NSN): 6505-01-054-4375 (6505010544375, 010544375)
| NIIN: |
01-054-4375 |
Item Name: |
DANTROLENE SODIUM CAPSULES |
INC: |
32518
|
| FSC: |
6505
|
Assignment Date: |
Jan-20-1978 |
CRIT: |
X |
IIG: |
32518 |
| ISC: |
5 |
Date Standardized: |
Jan-20-1978 |
HMIC: |
P |
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
Oct-22-2024 |
PMIC: |
U |
FIIG: |
A510U0 |
| ESD: |
|
Schedule B: |
3004.90.9290 |
DEMIL: |
A |
DEMIL INT: |
1 |
| TIIC: |
4 |
Originator: |
97 |
ADPEC: |
|
RPDMRC: |
3 |
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
35-0030-61 |
04489
|
NORWICH EATON PHARMACEUTICALS INC PROFESSIONAL PRODUCTS SUB OF PROCTER AND GAMBLE CO |
H |
3 |
2 |
4 |
75 |
1 |
D |
|
|
|
|
|
35-0030-61 |
04547
|
PROCTER & GAMBLE PHARMACEUTICALS, INC. |
H |
3 |
2 |
4 |
75 |
|
D |
|
|
|
|
|
DANTRIUM |
04489
|
NORWICH EATON PHARMACEUTICALS INC PROFESSIONAL PRODUCTS SUB OF PROCTER AND GAMBLE CO |
H |
5 |
1 |
4 |
75 |
1 |
D |
|
|
|
|
|
DANTRIUM |
04547
|
PROCTER & GAMBLE PHARMACEUTICALS, INC. |
H |
5 |
1 |
4 |
75 |
|
D |
|
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
25.000 MILLIGRAMS DANTROLENE SODIUM ACTIVE INGREDIENT |
| CQCT |
PRIMARY CONTAINER TYPE |
STRIP |
| CQLS |
CAPSULE CONTENT FORM |
POWDER |
| CSCW |
TOTAL PRIMARY CONTAINER QUANTITY |
1 |
| CYLZ |
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY |
100.000 |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| V540 |
|
Apr-01-1991 |
0 |
0 |
|
|
54 |
54 |
|